All treatments
Treatment
7 mikrog/dose nesespray clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic exploratory (Phase II)
A randomized, placebo-controlled, double-blind, 2-period cross-over study in youth with autism spectrum disorders evaluating social and repetitive behaviors after four weeks of twice daily-doses of 24IU of intranasally administered oxytocin
This study looks at how a nose spray with a substance called oxytocin might affect social skills and repetitive behaviours in young people with autism over four weeks. We want to see if it makes a difference.
For: Autism spectrum disorderNorway - AuthorisedTherapeutic exploratory (Phase II)
Effects of intranasal oxytocin in the treatment of benzodiazepine withdrawal: A pilot randomized parallel group placebo-controlled trial
This study is looking into whether a nasal spray containing oxytocin can help people reduce their dependence on benzodiazepine medication more effectively than current methods. They're comparing it to regular dose reduction and a dummy spray, focusing on easing withdrawal symptoms.
For: Benzodiazepine dependence (F13.2)Norway